STATE STREET CORP - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 173 filers reported holding REGENXBIO INC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of REGENXBIO INC
ValueSharesWeighting
Q2 2024$33,616,850
-48.9%
2,873,235
-8.0%
0.00%
-66.7%
Q1 2024$65,794,004
+39.3%
3,122,639
+18.7%
0.00%
+50.0%
Q4 2023$47,230,399
+14.6%
2,631,220
+5.1%
0.00%0.0%
Q3 2023$41,207,297
-25.4%
2,503,481
-9.4%
0.00%
-33.3%
Q2 2023$55,214,699
+13.1%
2,762,116
+7.0%
0.00%0.0%
Q1 2023$48,811,683
-60.4%
2,581,263
-52.5%
0.00%
-25.0%
Q4 2022$123,206,334
+77.9%
5,432,378
+107.3%
0.00%0.0%
Q3 2022$69,249,000
+0.1%
2,620,104
-6.5%
0.00%0.0%
Q2 2022$69,197,000
-21.4%
2,801,494
+5.6%
0.00%0.0%
Q1 2022$88,078,000
+8.2%
2,653,766
+6.6%
0.00%0.0%
Q4 2021$81,431,000
-20.0%
2,490,253
+2.6%
0.00%
-20.0%
Q3 2021$101,758,000
+15.7%
2,427,438
+7.2%
0.01%0.0%
Q2 2021$87,952,000
+12.3%
2,263,881
-1.4%
0.01%
+25.0%
Q1 2021$78,309,000
-5.2%
2,295,787
+26.0%
0.00%
-20.0%
Q4 2020$82,630,000
+40.1%
1,821,656
-15.0%
0.01%
+25.0%
Q3 2020$59,000,000
-28.7%
2,143,897
-4.5%
0.00%
-33.3%
Q2 2020$82,707,000
+29.9%
2,245,640
+14.2%
0.01%0.0%
Q1 2020$63,677,000
-17.2%
1,966,563
+4.8%
0.01%
+20.0%
Q4 2019$76,906,000
+2.9%
1,877,130
-10.5%
0.01%
-16.7%
Q3 2019$74,707,000
-29.2%
2,098,508
+2.1%
0.01%
-25.0%
Q2 2019$105,583,000
+10.1%
2,055,352
+22.8%
0.01%
+14.3%
Q1 2019$95,925,000
+15.8%
1,673,787
-15.2%
0.01%
-12.5%
Q4 2018$82,841,000
-35.3%
1,974,759
+16.5%
0.01%
-20.0%
Q3 2018$127,989,000
+33.7%
1,695,176
+27.1%
0.01%
+25.0%
Q2 2018$95,734,000
+166.0%
1,334,224
+10.7%
0.01%
+166.7%
Q1 2018$35,985,000
+0.7%
1,205,349
+12.2%
0.00%0.0%
Q4 2017$35,718,000
+36.4%
1,074,272
+35.1%
0.00%
+50.0%
Q3 2017$26,194,000
+50.5%
794,999
-9.7%
0.00%0.0%
Q2 2017$17,399,000
+184.6%
880,844
+178.1%
0.00%
+100.0%
Q1 2017$6,114,000
+7.1%
316,715
+2.9%
0.00%0.0%
Q4 2016$5,711,000
+50.1%
307,820
+13.4%
0.00%
Q3 2016$3,804,000
+99.3%
271,484
+13.9%
0.00%
Q2 2016$1,909,000
+100.9%
238,396
+170.8%
0.00%
Q1 2016$950,000
-0.4%
88,025
+53.0%
0.00%
Q4 2015$954,00057,5250.00%
Other shareholders
REGENXBIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,167,684$28,842,0009.84%
Sonic Fund II, L.P. 193,079$4,769,0002.91%
ArchPoint Investors 253,181$6,254,0002.48%
Redmile Group, LLC 2,004,663$49,515,0001.89%
Sofinnova Investments, Inc. 776,624$19,183,0001.60%
RTW INVESTMENTS, LP 1,845,366$45,581,0001.18%
WS MANAGEMENT LLLP 416,997$10,300,0000.84%
SILVERARC CAPITAL MANAGEMENT, LLC 104,129$2,572,0000.79%
HARBOR CAPITAL ADVISORS, INC. 30,251$747,0000.57%
Atom Investors LP 36,487$901,0000.39%
View complete list of REGENXBIO INC shareholders